About 40% of cancers among Americans can be attributed to potentially modifiable factors such as smoking, drinking, obesity, and physical inactivity. If a widely reported study from earlier this year ...

A high percentage of bladder cancers can be cured if they are found early. Once cancer spreads outside the bladder, it is much harder to treat. That’s why it’s important to first bring up any ...

Intravenous (IV) atezolizumab (Tecentriq, Genentech) is once again approved for bladder cancer. Following priority review, the FDA approved both IV atezolizumab and the newer subcutaneous formulation ...

Bladder cancer remains a major public health burden in the United States. The American Cancer Society estimates 84,870 new cases of bladder cancer and 17,420 deaths annually in the United States, ...

Therapeutic progress has accelerated, with multiple recent approvals improving outcomes across early-stage, muscle-invasive, and metastatic urothelial carcinoma. FGFR3 and HER2 protein expression by ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...